You are here

Article Text

Article menu
Download PDFPDF
Articles
Clarification: post-coital contraception (January 18, p 5)

Abstract

Wyeth have asked us to point out that the product licence for Ovran does not allow its use in post-coital contraception, and that such use is not recommended by the company. This applies equally to Schering’s Eugynon 50.

https://doi.org/10.1136/dtb.18.4.16

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.